Stocks and Investing Stocks and Investing
Wed, May 20, 2020

Leland Gershell Maintained (ASND) at Buy with Decreased Target to $208 on, May 20th, 2020


Published on 2024-10-27 06:44:34 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $219 to $208 on, May 20th, 2020.

Leland has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Adam Walsh of "Stifel" Maintained at Strong Buy with Increased Target to $171 on, Monday, April 20th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $201 on, Monday, April 20th, 2020
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $180 on, Thursday, April 2nd, 2020
Contributing Sources